(Q37216732)

19 August 2017

1 reference

title

The clinical impact of pharmacogenetics on the treatment of epilepsy (English)

1 reference

19 August 2017

Fritz Zimprich

3

0 references

author name string

Wolfgang Löscher

series ordinal

1

1 reference

19 August 2017

Ulrich Klotz

series ordinal

2

1 reference

19 August 2017

Dieter Schmidt

series ordinal

4

1 reference

19 August 2017

publication date

8 July 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

50

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

1-23

1 reference

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

Valproic acid teratogenicity: a toxicogenomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

Is the underlying cause of epilepsy a major prognostic factor for recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

Association of genetic loci: replication or not, that is the question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2008.01716.X

10.1111/J.1528-1167.2008.01716.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference